Cargando…
SARS-CoV-2 Vaccines and the Skin()
Vaccines against the severe acute respiratory coronavirus 2, which are the first to be used in humans against any coronavirus, were developed and produced in record time. Dermatologic adverse effects appeared during clinical trials and have also been described in the population since approval. Just...
Autores principales: | Galván-Casas, C., Català, A., Muñoz-Santos, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of AEDV.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401210/ https://www.ncbi.nlm.nih.gov/pubmed/34483343 http://dx.doi.org/10.1016/j.adengl.2021.07.028 |
Ejemplares similares
-
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
por: Carrascosa, J.M., et al.
Publicado: (2020) -
Vacunas frente a SARS-CoV-2 y piel
por: Galván-Casas, C., et al.
Publicado: (2021) -
Prurigo Nodularis Eruption Triggered by SARS-CoV-2 Vaccine
por: Barnawi, Ghassan, et al.
Publicado: (2022) -
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination
por: Wong, Nikita, et al.
Publicado: (2023) -
Morbilliform Rash: An Uncommon Herald of SARS-CoV-2
por: Kulkarni, Radhika B, et al.
Publicado: (2020)